BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37187591)

  • 1. IDO1 Promotes the Progression of NSCLC by Regulating the Polarization of M2 Macrophages.
    Chen X; Yao J; Zhang MY; Li R; Liu X; Qu YQ
    Int J Gen Med; 2023; 16():1713-1733. PubMed ID: 37187591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
    Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
    BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopoietin-like protein 2 facilitates non-small cell lung cancer progression by promoting the polarization of M2 tumor-associated macrophages.
    Wei X; Nie S; Liu H; Sun J; Liu J; Li J; Li S; Wang S; Han S; Wang J; Sun Y
    Am J Cancer Res; 2017; 7(11):2220-2233. PubMed ID: 29218246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Integrative Analysis Reveals the Association of
    Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
    Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
    Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
    J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-associated macrophage, angiogenesis and lymphangiogenesis markers predict prognosis of non-small cell lung cancer patients.
    Hwang I; Kim JW; Ylaya K; Chung EJ; Kitano H; Perry C; Hanaoka J; Fukuoka J; Chung JY; Hewitt SM
    J Transl Med; 2020 Nov; 18(1):443. PubMed ID: 33228719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Macrophage colony stimulating factor enhances non-small cell lung cancer invasion and metastasis by promoting macrophage M2 polarization].
    Li YJ; Yang L; Wang LP; Zhang Y
    Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):412-418. PubMed ID: 28635229
    [No Abstract]   [Full Text] [Related]  

  • 8. Oct4 promotes M2 macrophage polarization through upregulation of macrophage colony-stimulating factor in lung cancer.
    Lu CS; Shiau AL; Su BH; Hsu TS; Wang CT; Su YC; Tsai MS; Feng YH; Tseng YL; Yen YT; Wu CL; Shieh GS
    J Hematol Oncol; 2020 Jun; 13(1):62. PubMed ID: 32487125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTHRC1 in Ovarian Cancer Promotes M2-Like Polarization of Tumor-Associated Macrophages via Regulation of the STAT6 Signaling Pathway.
    Bai Y; Yin K; Su T; Ji F; Zhang S
    Onco Targets Ther; 2020; 13():5743-5753. PubMed ID: 32606786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-associated macrophages secret exosomal miR-155 and miR-196a-5p to promote metastasis of non-small-cell lung cancer.
    Li X; Chen Z; Ni Y; Bian C; Huang J; Chen L; Xie X; Wang J
    Transl Lung Cancer Res; 2021 Mar; 10(3):1338-1354. PubMed ID: 33889514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M2 tumor-associated macrophages promote tumor progression in non-small-cell lung cancer.
    Sumitomo R; Hirai T; Fujita M; Murakami H; Otake Y; Huang CL
    Exp Ther Med; 2019 Dec; 18(6):4490-4498. PubMed ID: 31777551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 13. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
    Yang LF; Zhang ZB; Wang L
    Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of NFATc1/c-myc/PKM2/IL-10 axis in activating cervical cancer tumor-associated M2 macrophage polarization to promote cervical cancer progression.
    Tan J; Yang L; Zhao H; Ai Y; Ren L; Zhang F; Dong W; Shi R; Sun D; Feng Y
    Exp Cell Res; 2022 Apr; 413(2):113052. PubMed ID: 35122827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGR5 deficiency activates antitumor immunity in non-small cell lung cancer
    Zhao L; Zhang H; Liu X; Xue S; Chen D; Zou J; Jiang H
    Acta Pharm Sin B; 2022 Feb; 12(2):787-800. PubMed ID: 35256947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
    Pang L; Han S; Jiao Y; Jiang S; He X; Li P
    Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ELANE Promotes M2 Macrophage Polarization by Down-Regulating PTEN and Participates in the Lung Cancer Progression.
    Song S; Zhao Y; Fu T; Fan Y; Tang J; Wang X; Liu C; Chen X
    Immunol Invest; 2023 Jan; 52(1):20-34. PubMed ID: 36102787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-derived exosomal circFARSA mediates M2 macrophage polarization via the PTEN/PI3K/AKT pathway to promote non-small cell lung cancer metastasis.
    Chen T; Liu Y; Li C; Xu C; Ding C; Chen J; Zhao J
    Cancer Treat Res Commun; 2021; 28():100412. PubMed ID: 34119765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
    Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
    BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.